AP
USNA icon

AHL Partners’s Usana Health Sciences USNA Stock Holding History

AHL Partners’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-89,919
Closed -$5.76M – 1298
2017
Q2 		$5.76M Buy
89,919
+424
+0.5% +$26.1K 0.12% 294
2017
Q1 		$5.16M Buy
89,495
+83,938
+1,510% +$5.01M 0.11% 326
2016
Q4 		$340K Sell
5,557
-1,921
-26% -$125K 0.01% 941
2016
Q3 		$517K Sell
7,478
-52,124
-87% -$3.44M 0.02% 827
2016
Q2 		$3.32M Sell
59,602
-41,636
-41% -$2.51M 0.18% 130
2016
Q1 		$6.15M Buy
101,238
+85,400
+539% +$5.03M 0.38% 67
2015
Q4 		$1.01M Buy
15,838
+12,358
+355% +$801K 0.08% 361
2015
Q3 		$233K Sell
3,480
-93,856
-96% -$6.64M 0.04% 632
2015
Q2 		$6.65M Buy
+97,336
New +$6.18M 0.27% 86

Other funds holding USNA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AHL Partners's USNA Position: Q3 2017 in Review

AHL Partners sold out of Usana Health Sciences (USNA) in Q3 2017, closing a stake of 89,919 shares — an estimated $5.76M sold.

AHL Partners first reported a position in USNA in Q2 2015 and held it in 9 quarters. The position peaked at $6.65M in Q2 2015. 144 funds tracked by Wall St. Rank hold USNA as of Q3 2017.

  • AHL Partners reported no remaining Usana Health Sciences position as of Q3 2017 after selling out during the quarter.
  • AHL Partners sold 89,919 Usana Health Sciences shares in Q3 2017, an estimated $5.76M.
  • AHL Partners first reported a position in Usana Health Sciences in Q2 2015 and held it in 9 quarters.
  • AHL Partners's Usana Health Sciences position peaked at $6.65M in Q2 2015.
  • 144 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2017.

Based on AHL Partners's 13F filing for Q3 2017, filed 14 Nov 2017.